Target intelligence / Profile preview

Blood glucose regulatory and antioxidant enzymes

Molecular classification
Enzyme
01

Overview

The term 'Blood glucose regulatory and antioxidant enzymes' refers to a broad functional collective of enzymes rather than a single molecular target. Blood glucose regulatory enzymes, such as Glucokinase (GCK), Hexokinase, and Glucose-6-phosphatase (G6PC), are essential for maintaining systemic glycemic homeostasis by managing the balance between glucose utilization and production (NIH, StatPearls: 'Physiology, Glucose Metabolism'). Antioxidant enzymes, including Superoxide dismutase (SOD), Catalase (CAT), and Glutathione peroxidase (GPx), serve as the primary defense mechanism against oxidative stress by neutralizing reactive oxygen species in mammalian tissues (NCBI: 'Antioxidant Enzymes and Their Role in Biological Systems'). In pathological states like Diabetes mellitus, the downregulation of antioxidant defenses often occurs alongside the dysregulation of glucose-metabolizing enzymes, leading to chronic tissue damage and metabolic dysfunction (PubMed: 'Oxidative stress in diabetes mellitus'). While individual enzymes within these groups are frequently targeted by pharmacological agents like Metformin or redox modulators, the collective phrase is typically used in research contexts to describe a physiological system rather than a specific drug-binding site.

Other names
Metabolic and redox enzymesGlucose-regulating enzymesAntioxidant defense system enzymesGlycemic regulatory enzymes
02

Mechanism of action

Varies by specific enzyme; includes the modulation of rate-limiting steps in glycolysis and gluconeogenesis, and the enzymatic neutralization of reactive oxygen species (ROS) such as superoxide and hydrogen peroxide.

03

Biological functions

Glucose metabolismRedox homeostasisCarbohydrate metabolismOxidative stress responseGlycolysisGluconeogenesis
04

Disease associations

Diabetes mellitusMetabolic syndromeCardiovascular diseaseNeurodegenerative diseaseObesity
05

Safety considerations

HypoglycemiaRedox imbalanceOff-target metabolic disruptionHepatotoxicity
06

Interacting drugs

Metformin

5 more in the full profile.

07

Biomarkers

Blood glucose levelsGlycated hemoglobin (HbA1c)Malondialdehyde (MDA)Reduced glutathione (GSH) levelsSuperoxide dismutase activity

Beyond the preview

Go deeper on Blood glucose regulatory and antioxidant enzymes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blood glucose regulatory and antioxidant enzymes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call